See all
 |
Articles: Lung/Thoracic Oncology |
Prior Articles
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Therapeutics and Clinical Risk Management, 09/29/09
Free full text
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer
Journal of Clinical Oncology, 09/28/09 Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels
Cancer Science, 09/28/09 Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet - Early Online Publication, 09/25/09 Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
Journal of Cancer Research & Clinical Oncology, 09/25/09 Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy
The Oncologist, 09/25/09 Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
The Oncologist, 09/25/09 Six-month prognosis of patients with lung cancer admitted to the intensive care unit
Intensive Care Medicine, 09/25/09 Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals
International Journal of Epidemiology, 09/25/09 Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
The Lancet - Early Online Publication, 09/24/09 Pemetrexed for the treatment of non-small-cell lung cancer
Expert Review of Anticancer Therapy, 09/24/09 Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
Journal of Cancer Research & Clinical Oncology, 09/24/09 Smoking and lung cancer: recent evidence and a discussion of some questions
International Journal of Epidemiology, 09/24/09
Revew Article
Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR
Medical Oncology, 09/24/09 p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients
Medical Oncology, 09/24/09 Spontaneous pyopneumothorax in patients treated with mTOR inhibitors for subpleural pulmonary metastases
Medical Oncology, 09/24/09 EUS-FNA in the preoperative staging of non-small cell lung cancer
Lung Cancer, 09/22/09 Response to gefitinib and erlotinib in non-small cell lung cancer: a retrospective study
BMC Cancer, 09/22/09
Free full text
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
Annals of Oncology, 09/22/09 Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non–Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine
Journal of Clinical Oncology, 09/21/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|